The device, Varipulse, is a pulsed field ablation system which uses small burns or freezes to cause some scarring in the ...
The technology is integrated with company’s electroanatomical mapping system, which helps guide operators during AF ablation.
Johnson & Johnson MedTech will enter the U.S. pulsed field ablation market following an FDA green light for its Varipulse ...
FDA approves Johnson & Johnson's Varipulse for targeted atrial fibrillation treatment, enhancing precision and safety ...
Johnson & Johnson MedTech announced today that the FDA approved its Varipulse pulsed field ablation (PFA) platform for ...
J&J is the third medtech company to gain U.S. approval for pulsed field ablation, a new atrial fibrillation treatment seeing ...
Johnson & Johnson MedTech division Biosense Webster has submitted a Premarket Approval Application (PMA) to the US Food and Drug Administration (FDA) for its VARIPULSE Platform, designed to treat ...